Rossio Kersey received her BS in Biological Sciences from Ricardo Palma University in Lima-Peru and worked as a Control pest Management Scientist at the International Potato Center. She traveled to the US to obtain her M.S. in Botany and Microbiology with minor in Biochemistry from OU. Under the sponsorship of OU, she confounded an International non-profit organization for the Biological Control of Pests and Pathogens in Lima-Peru and served as a VP for one year. She moved back to the US and received her Ph.D. in Molecular Biology from NMSU; there she founded, established and lead the first DNA Microarray Core Facility and created and lectured a hands-on DNA microarray analysis elective course. Later, she moved to Maryland and after 5 years of postdoc at the NIDDK-NHI, she became a Next Generation Sequencing (NGS) expertise. Afterwards, she worked for 2 years as a NGS Production Scientist in EdgeBio, for 4 years as a R&D Scientist Lead in OpGen Inc. where she led the development and validation of the first and only Multi-drug resistant organisms test to detect seven CRE (Carbapenem-resistant Enterobacteriaceae) critical genes from one swab, which has been recently patented. She is currently working as a R&D Principal Investigator in KamTek Inc. located in Frederick, MD. Her current research involves the repurposing of a promising drug to treat Clostridium difficile infections and to reduce relapse rates in the hospitals.